Bhatraphol Tingpej
Infectious Disease · Sumter, SCNPI 1497919831
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Viiv Healthcare Company at 41.0% of the total.
Across 174 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$1K
- Gilead$1K
- Merck$166
- Johnson & Johnson$109
- Amgen$98
- AbbVie$73
- plus $326 from 11 others
What the payments were for
- Food & beverage$3,488100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 72 | $1,431 |
| Gilead | 64 | $1,285 |
| Merck | 9 | $166 |
| Johnson & Johnson | 8 | $109 |
| Amgen | 1 | $98 |
| AbbVie | 4 | $73 |
| Theratechnologies Inc. | 3 | $60 |
| Novartis | 1 | $51 |
| Napo Pharmaceuticals Inc | 3 | $41 |
| Bayer | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $25 |
| Exact Sciences | 1 | $21 |
| Insulet Corporation | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $15 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,488 in reported general payments places this provider in the 75th percentile of 102 infectious disease providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 204 | $812,786 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 46 | $227,492 |
| DovatoDolutegravir Sodium/Lamivudine | 76 | $220,608 |
| TivicayDolutegravir Sodium | 59 | $157,238 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 24 | $100,542 |
| Egrifta SvTesamorelin Acetate | 13 | $97,862 |
| PrezcobixDarunavir/Cobicistat | 38 | $91,192 |
| JulucaDolutegravir/Rilpivirine | 25 | $84,443 |
| PifeltroDoravirine | 24 | $42,144 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 12 | $40,802 |
| EdurantRilpivirine Hcl | 15 | $21,850 |
| JardianceEmpagliflozin | 12 | $10,566 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 12 | $2,294 |
| Rosuvastatin Calcium | 141 | $683 |
| Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med | 27 | $607 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya | $1,285 | $913,328228 claims |
| Viiv Healthcare CompanyDovato, Tivicay, Juluca | $1,431 | $462,288160 claims |
| Theratechnologies Inc.Egrifta Sv | $60 | $97,86213 claims |
| Johnson & JohnsonPrezcobix | $109 | $91,19238 claims |
| MerckPifeltro | $166 | $42,14424 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 102 infectious disease providers in South Carolina.
Other infectious disease in Sumter
- Timothy HenkelHilton Head Island$1.8M
- Toby FugateCharleston$136K
- John McKinnonCharleston$85K
- John SchrankGreenville$74K
- Rishika MotianiFlorence$43K
- John GnannCharleston$39K
- John SamiesOrangeburg$18K
- Akinwale OlatosiCamden$17K
- Robert BallNorth Charleston$14K
- Eunice GuzmanMyrtle Beach$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.